Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FZX68
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,511
Award facts
- Contract value 100% obligated
- $2,510.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency for EXPAREL 266 mg/20 mL vials valued at $2,510.63. The contract is classified as firm fixed-price with an ultimate completion date of September 10, 2025. This delivery order was issued without a set-aside designation, reflecting DMS Pharmaceutical Group's competitive standing in the federal procurement market. The place of performance is located at the company's Park Ridge, Illinois facility.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499.999 billion through November 2026, which enables the issuance of firm fixed-price orders for comprehensive pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide. EXPAREL, a liposomal bupivacaine formulation used for prolonged anesthesia, represents one of the specialized pharmaceutical products within the scope of this IDC agreement. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides direct distribution of prescription drugs and medical consumables to military healthcare sites across the nation.
Quick answers
Who was awarded contract SPE2DB25FZX68?
SPE2DB25FZX68 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FZX68 worth?
The government has obligated $2,511 on SPE2DB25FZX68.
Is contract SPE2DB25FZX68 an order under another contract?
Yes. SPE2DB25FZX68 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX68 competed?
The extent of competition for SPE2DB25FZX68 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award